1 Safe-and-Steady Stock Worth Your Attention and 2 That Underwhelm

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here is one low-volatility stock that could succeed under all market conditions and two that may not keep up.

Two Stocks to Sell:

Tractor Supply (TSCO)

Rolling One-Year Beta: 0.51

Started as a mail-order tractor parts business, Tractor Supply (NASDAQ:TSCO) is a retailer of general goods such as agricultural supplies, hardware, and pet food for the rural consumer.

Why Does TSCO Worry Us?

1. Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 3% for the last three years
2. Lagging same-store sales over the past two years suggest it might have to change its pricing and marketing strategy to stimulate demand
3. Commoditized inventory, bad unit economics, and high competition are reflected in its low gross margin of 36.3%

Tractor Supply is trading at $53.80 per share, or 25.5x forward P/E. Check out our free in-depth research report to learn more about why TSCO doesn’t pass our bar.

ANI Pharmaceuticals (ANIP)

Rolling One-Year Beta: 0.41

With a diverse portfolio of 116 pharmaceutical products and a growing rare disease platform, ANI Pharmaceuticals (NASDAQ:ANIP) develops, manufactures, and markets branded and generic prescription pharmaceuticals, with a focus on rare disease treatments.

Why Is ANIP Not Exciting?

1. Modest revenue base of $826.9 million gives it less fixed cost leverage and fewer distribution channels than larger companies
2. Day-to-day expenses have swelled relative to revenue over the last five years as its adjusted operating margin fell by 4.5 percentage points
3. Push for growth has led to negative returns on capital, signaling value destruction

At $80.73 per share, ANI Pharmaceuticals trades at 10.3x forward P/E. Read our free research report to see why you should think twice about including ANIP in your portfolio.

One Stock to Buy:

Nelnet (NNI)

Rolling One-Year Beta: 0.72

Starting as a student loan servicer in the 1970s and evolving through the changing landscape of education finance, Nelnet (NYSE:NNI) provides student loan servicing, education technology, payment processing, and banking services while managing a portfolio of education loans.

Why Is NNI a Good Business?

1. Annual revenue growth of 18% over the past two years was outstanding, reflecting market share gains this cycle
2. Share repurchases over the last two years enabled its annual earnings per share growth of 37.2% to outpace its revenue gains
3. Adequate return on equity shows management makes decent investment decisions

Nelnet’s stock price of $129.91 implies a valuation ratio of 16.2x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

Stocks We Like Even More

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.